Coordinating Committee

Initial steps to establish the Enterprise were undertaken by a self-appointed Steering Committee. This committee was subsequently replaced by a Coordinating Committee which has been the primary body responsible for setting the strategic direction of the Enterprise in conjunction with the interim Secretariat.

Current Coordinating Committee members include:

• Seth Berkley
  International AIDS Vaccine Initiative, U.S.
• M.K. Bhan
  Ministry of Science & Technology, India
• Michel De Wilde
  Sanofi-Pasteur, France
• José Esparza (Head of the interim Secretariat)
  Bill & Melinda Gates Foundation, US
• Anthony Fauci
  National Institutes of Health, U.S.
• Helene Gayle
  CARE USA
• Catherine Hankins
  Joint United Nations Programme on HIV/AIDS
• Margaret Johnston
  National Institutes of Health, U.S.
• Pontiano Kaleebu
  African AIDS Vaccine Programme, Uganda

• Edward Karamov
  Institute of Virology, Russia
• Eric Lander
  Broad Institute of MIT and Harvard University, U.S.
• Malegapuru William Makgoba
  University of KwaZulu-Natal, South Africa
• Pascoal Mocumbi
  European and Developing Countries Clinical Trials Partnership, E.U.
• Octavi Quintana Trias
  European Commission, E.U.
• Rino Rappuoli
  Chiron Corporation, Italy
• William Snow
  AIDS Vaccine Advocacy Coalition, U.S.
• Mark Walport
  Wellcome Trust, U.K.